Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Accounts Payables (2016 - 2025)

Cosmos Health's Accounts Payables history spans 13 years, with the latest figure at $14.6 million for Q4 2025.

  • Quarterly results put Accounts Payables at $14.6 million for Q4 2025, up 31.07% from a year ago — trailing twelve months through Dec 2025 was $14.6 million (up 31.07% YoY), and the annual figure for FY2025 was $14.6 million, up 31.07%.
  • Accounts Payables for Q4 2025 was $14.6 million at Cosmos Health, up from $14.3 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $14.6 million in Q4 2025 to a low of $193894.0 in Q2 2021.
  • The 5-year median for Accounts Payables is $11.5 million (2022), against an average of $10.7 million.
  • Peak annual rise in Accounts Payables hit 5661.64% in 2022, while the deepest fall reached 98.05% in 2022.
  • Year by year, Accounts Payables stood at $12.1 million in 2021, then decreased by 16.43% to $10.1 million in 2022, then rose by 17.54% to $11.9 million in 2023, then fell by 6.33% to $11.2 million in 2024, then surged by 31.07% to $14.6 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $14.6 million, $14.3 million, and $13.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.